Mnemosyne Pharmaceuticals' Seed VC Round

Mnemosyne Pharmaceuticals raised a round of funding on June 16, 2010. Investors include Slater Technology Fund.

Mnemosyne Pharmaceuticals is a drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders. The company is exploring …

Articles about Mnemosyne Pharmaceuticals' Seed VC Round: